The Dysregulation of mir-21 and mir-143 as a clinical Marker for Cancer Stem Cells in Tissue Samples of Iraqi Male Patients with Gastrointestinal Sarcoma. Journal of Pharmaceutical Negative Results, [S. l.], v. 13, n. 3, p. 20–25, 2022. DOI: 10.47750/pnr.2022.13.03.004. Disponível em: https://pnrjournal.com/index.php/home/article/view/217.. Acesso em: 19 jul. 2024.